Avery Dennison Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated April 28, 2022, reports on the Annual Meeting of Stockholders held virtually due to COVID-19 concerns. The filing covers corporate governance actions and a new capital allocation authorization.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The only financial metric disclosed is the authorization of a new share repurchase program with a fair market value of up to $750 million.
Material Changes and Corporate Actions
- Share Repurchase Authorization: The Board authorized the repurchase of up to $750 million of common stock, in addition to any amounts outstanding under previous authorizations.
- Board Elections: Stockholders elected eight directors (Bradley Alford, Anthony Anderson, Mitchell Butier, Ken Hicks, Andres Lopez, Patrick Siewert, Julia Stewart, and Martha Sullivan) to one-year terms.
- Executive Compensation: Stockholders approved, on an advisory basis, the Company's executive compensation.
- Auditor Ratification: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2022.
Voting Results
| Proposal | For | Against | Abstain |
|---|---|---|---|
| Director Nominees (All 8) | 60.9M - 68.2M | 0.5M - 6.0M | 77K - 1.9M |
| Executive Compensation (Advisory) | 64,926,263 | 3,691,931 | 166,532 |
| Auditor Ratification | 68,470,561 | 4,062,729 | 459,567 |
Approximately 89% of eligible shares were represented at the meeting, constituting a quorum.
Outlook and Risks
The filing does not contain management commentary on future financial guidance, specific risks, or contingencies beyond the context of the virtual meeting format.
Investor Verification Checklist
- Verify the total remaining capacity of the share repurchase program by adding the new $750 million authorization to any previously authorized but unutilized amounts.
- Review the 2022 Proxy Statement (filed March 10, 2022) for detailed biographies of the newly elected directors and specific executive compensation metrics.
- Confirm the timing and execution of the new share repurchases in subsequent filings.